AVANTEL LTD.

Avantel Ltd has announced the receipt of a significant contract from the Defence Research and Development Organisation (DRDO), Ministry of Defence, Government of India. The contract, valued at ₹117.88 Crores (inclusive of taxes), is for the Development, Installation & Commission of a Ground Segment Hub for voice & data communication. The project is slated for execution by February 2029, with a warranty period of 36 months. This award underscores Avantel's role in supporting critical defence infrastructure development for the Indian government.

Avantel Ltd announced that its members have approved the re-appointment of Mr. Abburi Siddhartha Sagar as Executive Director (Strategy & Business Development) for a five-year term from March 8, 2027, to March 7, 2032. Additionally, Mr. Peddi Bala Bhaskar Rao has been appointed as Director (Operations) for a three-year term from July 11, 2026, to July 10, 2029. The members also approved the re-appointment of Mr. Vyasabhattu Ramchander as an Independent Director for a second five-year term from May 6, 2027, to May 5, 2032. All appointments were approved via postal ballot and remote e-voting on August 16, 2026. The company also confirmed that the voting results and scrutineer's report are being submitted separately.

Avantel Ltd has announced the receipt of a significant purchase order worth ₹20.81 Crores (inclusive of applicable taxes) from Larsen & Toubro Limited (L&T). The order is for services related to SATCOM Products and is expected to be executed by July 2027. This contract marks a positive development for Avantel, strengthening its order book and demonstrating continued business with a major industry player. The company has provided the necessary disclosures as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Avantel Ltd has dispatched communication letters to shareholders whose email addresses are not registered with the company, its Registrar and Share Transfer Agent, or Depository Participants. This communication provides a web link to the company's website for accessing the Notice of Postal Ballot dated July 11, 2026, and details the Postal Ballot process. It also facilitates the registration of email addresses for future communications. The Notice of Postal Ballot is available on the company's website and stock exchange websites. Key dates for the postal ballot process include a cut-off date of July 14, 2026, for voting entitlement, with remote e-voting commencing on July 18, 2026, and ending on August 16, 2026.

Avantel Ltd has received a Monitoring Agency Report from CARE Ratings Limited for the quarter ended June 30, 2026. The report confirms that the proceeds from the company's Rights Issue have been utilized for the purposes outlined in the Letter of Offer, with no deviation or variation. The report was reviewed and taken on record by Avantel's Audit Committee and Board of Directors on July 11, 2026. The Rights Issue aggregated to Rs. 80.91 crore.

Avantel Ltd announced that its Board of Directors, in a meeting held on July 11, 2026, approved key personnel changes and committee re-constitutions. Mr. Abburi Siddhartha Sagar was re-appointed as Executive Director (Strategy & Business Development) for five years from March 8, 2027. Mr. Peddi Bala Bhaskar Rao was appointed as Additional Director (Operations) for three years from July 11, 2026. Mr. Vyasabhattu Ramchander was re-appointed as Independent Director for a second five-year term from May 6, 2027. All appointments are subject to shareholder approval via postal ballot. The Board also reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee.

Avantel Ltd announced that its Board of Directors, in a meeting held on July 11, 2026, approved key personnel changes and committee reconstitutions. Mr. Abburi Siddhartha Sagar was re-appointed as Executive Director (Strategy & Business Development) for five years from March 8, 2027. Mr. Peddi Bala Bhaskar Rao was appointed as an Additional Director, Director (Operations) for three years from July 11, 2026. Mr. Vyasabhattu Ramchander was re-appointed as an Independent Director for a second five-year term from May 6, 2027. All appointments are subject to shareholder approval via postal ballot. The Board also reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee with immediate effect.

Avantel Ltd announced that its Board of Directors, in a meeting held on July 11, 2026, approved the un-audited standalone and consolidated financial results for the first quarter and three months ended June 30, 2026. The board also approved a revision in remuneration for Executive Director Mr. Abburi Siddhartha Sagar to ₹55 Lakhs per annum, effective July 11, 2026. Additionally, the re-appointment of Mr. Sagar as Executive Director for a further five-year term and the appointment of Mr. Peddi Bala Bhaskar Rao as Additional Director (Operations) for three years were approved, subject to shareholder approval via postal ballot. The re-appointment of Mr. Vyasabhattu Ramchander as Independent Director for a second five-year term was also approved, pending shareholder consent. The Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee were reconstituted.

Avantel reported strong Q1 FY-2027 results with consolidated revenue ₹70.42 Cr, up 35.6% YoY and 10.3% QoQ, while net profit surged 67.1% to ₹5.39 Cr from ₹3.23 Cr a year ago and ₹4.77 Cr in Q4 FY-2026. The Communications & Signal Processing segment (core business, 99.6% of revenue) delivered ₹70.23 Cr and PBT of ₹10.92 Cr; the wholly-owned Healthcare subsidiary (iMeds) contributed only ₹30.4 Lakhs in revenue but posted a ₹2.22 Cr loss. Operating margin compressed sharply to 12.4% from 20.1% YoY and 21.3% QoQ, driven by elevated depreciation of ₹7.10 Cr stemming from recent capex investment in manufacturing infrastructure; net profit margin expanded to 7.7% YoY (from 6.2%) but was flat QoQ (7.35%). The 29% gap between standalone PAT (₹7.62 Cr) and consolidated (₹5.39 Cr) reflects the healthcare subsidiary's drag—a structural issue investors should monitor as management develops this segment. Consolidated EPS declined to ₹0.20 from ₹0.32 YoY despite strong profit growth, indicating material share dilution from ESOP issuance (₹135.59 Lakhs in option expense this quarter). The company's principal customer is government-controlled, eliminating loss allowance risk. Strong topline growth (+36% YoY) and profit expansion (+67%) demonstrate solid business momentum, but the significant margin compression warrants close monitoring to assess whether capex-driven depreciation represents a cyclical trough or signals structural operating leverage challenges. Management has not provided FY-2027 guidance.

Avantel Ltd has announced that its Board of Directors will convene on July 11, 2026, to consider and approve the Unaudited Financial Results for the First Quarter ended June 30, 2026. In line with SEBI regulations, the company has also closed its trading window from July 1, 2026, and it will remain shut for 48 hours post-declaration of the financial results to prevent insider trading. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.